Wednesday, February 10, 2010, 7:04am EST - Canadian Markets open in 2 hours and 26 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

SurModics Inc. (SRDX)

 On Feb 9: 19.66 USD   0.00 (0.00%)  
MORE ON SRDX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
SurModics, Inc. (NasdaqNM:SRDX) Delayed quote dataEdit
Last Trade: 19.66 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 19.66
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 22.50
Day's Range: N/A - N/A
52wk Range: 15.96 - 31.00
Volume: 0
Avg Vol (3m): 99,773
Market Cap: 341.99M
P/E (ttm): 27.61
EPS (ttm): 0.71
Div & Yield: N/A (N/A%)
SurModics Inc. (SRDX)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add SRDX to Portfolio   Download Data

HEADLINES
• SurModics to Webcast Annual Meeting February 8
Business Wire (Mon, Feb 1)
• SurModics Beats
Zacks.com (Fri, Jan 29)
• New Star Analyst Rankings for SurModics, Inc.
StarMine (Thu, Jan 28)
• SurModics, Inc. F1Q10 (Qtr End 12/31/09) Earnings Call Transcript
at Seeking Alpha (Thu, Jan 28)
• SurModics, Inc. Earnings Call scheduled for 5:00 pm ET today
CCBN (Wed, Jan 27)
• SURMODICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, Jan 27)
• SurModics Reports First Quarter 2010 Results
Business Wire (Wed, Jan 27)
• Q1 2010 SurModics, Inc. Earnings Release - After Market Close
CCBN (Wed, Jan 27)
• SurModics Inc. opens new facility
at bizjournals.com (Thu, Jan 21)
• SurModics Opens World-Class cGMP Facility for Manufacturing and Development in Birmingham, Alabama
Business Wire (Thu, Jan 21)
• SurModics to Webcast First Quarter Fiscal Year 2010 Earnings Conference Call January 27
Business Wire (Wed, Jan 13)
More Headlines for SRDX...
ANALYST
EPS Est (next year) (Sep-10) : 0.72
EPS Est (in 2 years) (Sep-11) : 0.99
Avg Rec (current)*: 2.7
PEG Ratio: 1.84
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
SurModics, Inc. engages in the development, manufacture, and sale of surface modification and drug delivery technologies to the healthcare industry. The company operates through four business units: Cardiovascular, Ophthalmology, SurModics Pharmac...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices